"active immunisation" - Google News
[unable to retrieve full-text content]
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial Nature.com[unable to retrieve full-text content]
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial Nature.com
Comments
Post a Comment